Sorrento Therapeutics, Inc.
(NASDAQ : SRNE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.57%183.811.3%$480.26m
ARRYArray BioPharma Inc.
0.15%46.578.1%$427.13m
CELGCelgene Corporation
0.36%98.191.3%$407.54m
GILDGilead Sciences, Inc.
0.35%68.500.9%$394.90m
BIIBBiogen Inc.
0.59%235.271.3%$352.75m
ILMNIllumina, Inc.
1.42%356.933.5%$286.21m
REGNRegeneron Pharmaceuticals, Inc.
3.15%320.622.6%$240.74m
VRTXVertex Pharmaceuticals Incorporated
0.66%182.941.9%$218.13m
AAgilent Technologies, Inc.
0.21%72.801.6%$195.63m
EXASExact Sciences Corporation
-0.61%115.2824.1%$188.00m
ALXNAlexion Pharmaceuticals, Inc.
3.75%128.412.0%$184.65m
BMRNBioMarin Pharmaceutical Inc.
1.49%86.294.3%$129.74m
SRPTSarepta Therapeutics, Inc.
-2.67%130.8314.7%$109.38m
INCYIncyte Corporation
2.11%86.662.5%$108.69m
MRTXMirati Therapeutics Inc.
3.41%104.682.5%$101.75m

Company Profile

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.